A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16

Neoplasia

Volumn 10, Issue 1, 2008, Pages 69-78

  Kim, Marianne K H ^a   Mason, Jacqueline M ^b   Li, Chi Ming ^c   Berkofsky Fessler, Windy ^d   Jiang, Le ^e   Choubey, Divaker ^f   Grundy, Paul E ^g   Tycko, Benjamin ^e   Licht, Jonathan D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c AMGEN INC   (United States)

^d HOFFMANN LA ROCHE INC   (United States)

^e Columbia University College of Physicians and Surgeons ^*  (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE; PROTEIN IFI16; UNCLASSIFIED DRUG; WT1 PROTEIN;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GESTATION PERIOD; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY PARENCHYMA; NEPHROBLASTOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SUPPRESSOR GENE;

EID: 38649105182     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07869     Document Type: Article

References (27)

1. Englert C, Maheswaran S, Garvin AJ, Kreidberg J, and Haber DA (1997). Induction of p21 by the Wilms' tumor suppressor gene WT1. Cancer Res 57, 1429-1434.
2. English MA and Licht JD (1999). Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control. J Biol Chem 274, 13258-13263.
3. Morrison DJ, English MA, and Licht JD (2005). WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak. Cancer Res 65, 8174-8182.
4. Hosono S, Luo X, Hyink DP, Schnapp LM, Wilson PD, Burrow CR, Reddy JC, Atweh GF, and Licht JD (1999). WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts. Oncogene 18, 417-427.
5. Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re GG, Garvin AJ, Rosner MR, and Haber DA (1995). WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14, 4662-4675.
6. Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, Sugiyama H, and Noguchi S (2002). High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 8, 1167-1171.
7. Yang L, Han Y, Saurez Saiz F, and Minden MD (2007). A tumor suppressor and oncogene: the WT1 story. Leukemia .
8. Kwak JC, Ongusaha PP, Ouchi T, and Lee SW (2003). IFI16 as a negative regulator in the regulation of p53 and p21(Waf1). J Biol Chem 278, 40899-40904.
9. Aglipay JA, Lee SW, Okada S, Fujiuchi N, Ohtsuka T, Kwak JC, Wang Y, Johnstone RW, Deng C, Qin J, et al. (2003). A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway. Oncogene 22, 8931-8938.
10. Johnstone RW, Kerry JA, and Trapani JA (1998). The human interferon-inducible protein, IFI 16, is a repressor of transcription. J Biol Chem 273, 17172-17177.
11. Xin H, Curry J, Johnstone RW, Nickoloff BJ, and Choubey D (2003). Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence. Oncogene 22, 4831-4840.
12. Kim EJ, Park JI, and Nelkin BD (2005). IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. J Biol Chem 280, 4913-4920.
13. Xin H, Pereira-Smith OM, and Choubey D (2004). Role of IFI 16 in cellular senescence of human fibroblasts. Oncogene 23, 6209-6217.
14. Fujiuchi N, Aglipay JA, Ohtsuka T, Maehara N, Sahin F, Su GH, Lee SW, and Ouchi T (2004). Requirement of IFI16 for the maximal activation of p53 induced by ionizing radiation. J Biol Chem 279, 20339-20344.
15. Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, et al. (2004). CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors. Am J Pathol 165, 1943-1953.
16. Reddy JC, Morris JC, Wang J, English MA, Haber DA, Shi Y, and Licht JD (1995). WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J Biol Chem 270, 10878-10884.
17. Reddy JC, Hosono S, and Licht JD (1995). The transcriptional effect of WT1 is modulated by choice of expression vector. J Biol Chem 270, 29976-29982.
18. Gross I, Morrison DJ, Hyink DP, Georgas K, English MA, Mericskay M, Hosono S, Sassoon D, Wilson PD, Little M, et al. (2003). The receptor tyrosine kinase regulator Sprouty1 is a target of the tumor suppressor WT1 and important for kidney development. J Biol Chem 278, 41420-41430.
19. Kim MK and Carroll WL (2004). Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2. Cancer 101, 2106-2115.
20. Hosono S, Gross I, English MA, Hajra KM, Fearon ER, and Licht JD (2000). E-cadherin is a WT1 target gene. J Biol Chem 275, 10943-10953.
21. Lee SB, Huang K, Palmer R, Truong VB, Herzlinger D, Kolquist KA, Wong J, Paulding C, Yoon SK, Gerald W, et al. (1999). The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell 98, 663-673.
22. Udtha M, Lee SJ, Alam R, Coombes K, and Huff V (2003). Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors. Oncogene 22, 3821-3826.
23. Palmer RE, Kotsianti A, Cadman B, Boyd T, Gerald W, and Haber DA (2001). WT1 regulates the expression of the major glomerular podocyte membrane protein podocalyxin. Curr Biol 11, 1805-1809.
24. Shen HL, Chen ZX, Wang W, Cen JN, Hu SY, and Zhao Y (2006). Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4. Ai Zheng 25, 163-169.
25. Sim EU, Smith A, Szilagi E, Rae F, Ioannou P, Lindsay MH, and Little MH (2002). Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. Oncogene 21, 2948-2960.
26. Lovvorn HN, Westrup J, Opperman S, Boyle S, Shi G, Anderson J, Perlman EJ, Perantoni AO, Wills M, and de Caestecker M (2007). CITED1 expression in Wilms' tumor and embryonic kidney. Neoplasia 9, 589-600.
27. Rong Y, Cheng L, Ning H, Zou J, Zhang Y, Xu F, Liu L, Chang Z, and Fu XY (2006). Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor. Cancer Res 66, 8049-8057.